Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Sales Rise 14.9 Percent; Raises 2008 EPS Forecast

NEW YORK (GenomeWeb News) – Sigma-Aldrich last night reported a 14.9 percent increase in first-quarter sales, helped by a 7.6 percent benefit from currency translation, and a 12.8 percent gain in profits year over year.
 
The St. Louis-based chemicals and life science research products firm brought in revenues of $569.6 million for the three-month period ended March 31, compared to revenues of $495.9 million for the comparable period a year ago. The firm’s organic growth rate for the quarter was 6.5 percent, excluding the currency effects and acquisition of Epichem in February 2007.
 
Sales growth for its Research Specialties business was 13.9 percent, rising to $213.3 million, while sales for the Research Essentials business climbed 10.8 percent to $110.1 million. Sales for the Research Biotech business increased 16.7 percent to $88.7 million, and sales for the SAFC business jumped 18.2 percent to $157.5 million.
 
Sigma-Aldrich posted net income of $84.5 million, or $.64 per share, compared with net income of $74.9 million, or $.56 per share, in the first quarter of 2007.
 
The firm’s R&D expenses increased 12.8 percent to $15.9 million from $14.1 million, while its SG&A costs rose 16.4 percent to $147.7 million from $126.9 million.
 
Sigma-Aldrich finished the quarter with $226.4 million in cash and cash equivalents.
 
The firm is targeting 2008 organic sales growth of 7 percent, with currency effects expected to add an additional 6 percent of growth. It also raised its 2008 earnings per share guidance by $.05 to a range of between $2.57 and $2.67.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.